General approach toward aspidospermatan-type alkaloids using one-pot Vilsmeier–Haack cyclization and azomethine ylide cycloaddition by Hauduc, Clémence & Bélanger, Guillaume
General Approach toward Aspidospermatan-Type Alkaloids Using
One-Pot Vilsmeier−Haack Cyclization and Azomethine Ylide
Cycloaddition
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ABSTRACT: The development of a new one-pot reaction
sequence afforded the tricyclic core of several aspidosperma-
tan-type alkaloids from a linear, densely functionalized
substrate. The key sequence features a highly chemoselective
formamide activation that triggered a Vilsmeier−Haack
cyclization, followed by an azomethine ylide generation and
intramolecular cycloaddition. The choice of nucleophile,
azomethine ylide precursor, and dipolarophile was crucial to
the success of the sequence.
■ INTRODUCTION
Aspidospermatan-type alkaloids are a rich class of indole
alkaloids bearing a unique bridged 1-azatricyclo[5.2.2.04,9]-
undecane core (Figure 1). Despite several efforts toward the
synthesis of members of this family,1 efficient, short, and versatile
synthetic routes are still coveted.
As part of our research in the development of new one-pot
reaction sequences to access functionalized cores of polycyclic
alkaloids,2 we envisaged a unified approach toward several
members of the aspidospermatan-type alkaloids. Key inter-
mediate 4 was seen as a common precursor to a series of natural
products by functional group manipulations and introduction of
the indoline moiety using the ketone on 4 (Scheme 1).3 After
amination, the indoline would be prepared by radical
dehalogenation of 3a, followed by hydrogen abstraction on
intermediate 2 and oxidative radical cyclization.4 Alternatively,
the same intermediate 1 may also be accessed from a radical
decarboxylation of ester 3b.5 Common precursor 4 would be the
direct product of the highlighted one-pot Vilsmeier−Haack
cyclization of formamide 6 upon activation and nucleophilic
trapping, followed by in situ azomethine ylide 5 generation and
intramolecular cycloaddition. The required amide 6 would be
derived from nitro 7, the enone (dipolarophile) from an alcohol,
and the nucleophilic allylsilane from aldehyde 7. The latter would
come from alkylation of protected hydroxyaldehyde 8.
■ RESULTS AND DISCUSSION
The synthesis of the key step substrate 6 started with known
aldehyde 96 that was subjected to a pyrrolidine catalyzed
conjugate addition to nitroethylene (Scheme 2).7 The allylsilane
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Figure 1. Selection of aspidospermatan alkaloids targets.
Scheme 1. Retrosynthesis Analysis of Common Precursor 4
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nucleophile required for the Vilsmeier−Haack reaction was
installed on racemic aldehyde 10 through a vinyl Grignard
addition, acylation, and SN2′ displacement with TMS using
Tsuji’s conditions.8 Acidic methanolysis of silyl ether 13 followed
by Dess-Martin oxidation produced aldehyde 14. After another
vinyl Grignard addition, the resulting allylic alcohol 15 was
obtained as a 1:1 mixture of diastereomers.9 The nitro group was
then reduced with zinc dust in weak acidic conditions10 that were
tolerated by the sensitive allylsilane. The resulting amine was
alkylated with (iodomethyl)trimethylsilane and then formylated
using Katritzky’s reagent11 to afford formamide 16. A Dess-
Martin periodinane (DMP) oxidation of the latter generated
compound 6 ready for testing the full cyclization sequence.
Key step substrate 6 was treated with triflic anhydride in the
presence of 2,6-di-tert-butyl-4-methylpyridine (DTBMP) to
effect the amide activation and Vilsmeier−Haack reaction
(Scheme 3). Unfortunately, we were not able to observe the
formation of iminium ion 17 or 18 by 1H NMR spectral analysis,
although following such reactions using this technique is
routinely done in our laboratory.2
At this point, we hypothesized that the enone was too reactive
and did not withstand the activation conditions, even when the
reaction was started at −78 °C. To confirm this hypothesis,
substrate 19 was prepared by benzylation of alcohol 16 (Scheme
4). When formamide 19 was activated, nonconjugated iminium
ion intermediate 20 was observed by 1H NMR spectroscopy.
After 4 h at room temperature, conversion into eniminium ion 21
was complete. Conjugation could also be effected by addition of
an excess of DTBMP, or by purification of the iminium ion
intermediate using flash chromatography. Unfortunately, any
attempt to generate the azomethine ylide by desilylation of 20 or
21 and further intramolecular trapping of the corresponding
azomethine ylide failed.
This result did not allow a conclusion as to whether the failure
to generate cycloadduct 22 was due to a reluctant desilylation of
iminium ion 20/21 or to a lack of reactivity of either the
corresponding azomethine ylide or the dipolarophile in the
cycloaddition step. Because this information was crucial to design
a successful cycloaddition, we purified iminium ion 21 and
treated the latter with tetrabutylammonium difluorotriphenyl-
silicate (TBAT) in the presence of an excess of N-phenyl-
maleimide at different temperatures. Cycloadduct 23 was
obtained, albeit in moderate yield.12 Hence, these results
demonstrated that the key cyclization sequence is viable, but
we needed to adjust the electronic character of the internal
alkene dipolarophile to enhance its reactivity.13 Therefore, we
chose to add an ester as a mild electron-withdrawing group on
the dipolarophile (Scheme 5).2 We opted to install the ester
group on the internal alkene carbon so that it could
advantageously be used to guide the regioselective indoline
formation later on.5 The synthesis of the new targeted key step
substrate began with reduction of nitro 13 followed by alkylation
with (iodomethyl)trimethylsilane and formylation11 to afford
formamide 24. Silyl ether deprotection and Dess-Martin
oxidation of the resulting alcohol 26 gave aldehyde 28 in
excellent yield. The ester was installed using a Baylis−Hillman
reaction14 followed by benzylation to give the desired substrate
32.15
Scheme 2. Synthesis of Key Step Substrate 6
Scheme 3. Attempted Vilsmeier−Haack/Azomethine Ylide
Cycloaddition Sequence with Enone 6
Scheme 4. Attempted Vilsmeier−Haack/Azomethine Ylide
Cycloaddition Sequence with Protected Allylic Alcohol 19
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Formamide 32 was treated with triflic anhydride, and the
Vilsmeier−Haack cyclization generated the nonconjugated
iminium ion 34 which converted over time (or after flash
chromatography) to conjugated iminium ion 35 (Scheme 6).
Unfortunately, upon addition of a desilylation agent (TBAC or
TBAT) to iminium ion 35, the latter decomposed. We suspected
a conjugate addition of the desilylation agent to the unsaturated
ester, followed by possible polymerization, as observed with N-
phenylmaleimide in the formation of cycloadduct 23 (Scheme
4).
To avoid such side reactions, the obvious solution was to
rather prepare the azomethine ylide by deprotonation instead of
desilylation. We thus switched to a stabilized azomethine ylide
bearing a nitrile. The key step precursor was prepared using the
same route described previously (Scheme 5), except that the
amine resulting from zinc reduction of nitro 13 was alkylated
with bromoacetronitrile. TBS deprotection, oxidation, and
Baylis−Hillman reaction14,15 generated compound 31 in yields
slightly better than that for the TMS analogue 30. After a TES
protection of the free alcohol 31, key step precursor 33 was
obtained in only 11 steps.16
Subjection of formamide 33 to the Vilsmeier−Haack
conditions afforded conjugated iminium ion 39 as confirmed
by 1H NMR spectral analysis (Scheme 7).17 In this particular
case, tautomerization was fast and we could not observe the
nonconjugated iminium ion 37 intermediate. Addition of i-
Pr2NEt at room temperature generated only the cycloadduct 41
bearing a terminal alkene, but in a trace amount.18 At first glance,
the terminal alkene in 41 seems inconsistent with the
cycloaddition of conjugated iminium ion 39. To explain this
result, we postulate that, upon addition of Hunig’s base, iminium
ion 39 is deprotonated to dienamine 38, the resting state in
solution. Small amounts of protonated iminium ion 37,
kinetically favored over 39, lead to azomethine ylide 40, further
trapped in the cycloaddition to produce 41. We could presume
that dienamine 38 is decomposed over time, to account for the
poor cycloaddition yield.
To prevent any enolization issue, the allylsilane was replaced
with a methyl enol ether (Scheme 8). Hence, Wittig olefination
of aldehyde 10 afforded a separable 3:1 mixture of E/Z isomers.
Only the E-isomer 42 was used for the rest of the synthesis.19
Following the sequence previously developed, reduction of the
nitro group, alkylation with bromoacetonitrile, and in situ
formylation11 afforded formamide 43 in 76% overall yield. After
Scheme 5. Synthesis of Key Step Substrates 32 and 33
Scheme 6. Attempted Vilsmeier−Haack/Azomethine Ylide
Cycloaddition Sequence with Unsaturated Ester 32
Scheme 7. Vilsmeier−Haack/Cycloaddition Sequence with
Stabilized Azomethine Ylide
Scheme 8. Synthesis of Key Step Substrate 46
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desilylation and oxidation, the resulting aldehyde 44 was treated
under Baylis−Hillman conditions14,15 with methyl acrylate to set
the dipolarophile. Finally, acetylation20 of alcohol 45 provided
the key step substrate 46 in only eight steps from aldehyde 9.
Upon activation of formamide 46, the intramolecular
Vilsmeier−Haack reaction proceeded in less than 5 min at
room temperature leading to iminium ion 49 (Scheme 9).
Thereafter, the mixture was diluted in chlorobenzene and heated
to 125 °Cprior to the addition of i-PrNEt2.
21 This way, as soon as
the deprotonation α to cyano on iminium ion intermediate 49
occurs, the corresponding stabilized azomethine ylide 50 can
adopt the reactive conformation 50b and immediately undergoes
intramolecular cycloaddition. The cycloadduct was generated in
a mixture of diastereoisomers in only 20 min and in 47% yield.
Fortunately, one of the diastereomers (51) crystallized out of the
mixture and X-ray diffraction confirmed the structure.22
The structure of the other diastereomers will need to be
confirmed, but data point toward the cismethyl enol ether as the
second major diastereomer. Minor diastereomers are usually
epimers at the pyrrolidine carbon bearing the nitrile in such
reaction cascades.2 Fortunately, all these diastereomers will
eventually lead to the same common precursor 4.
■ CONCLUSION
In conclusion, we successfully developed a sequential Vilsmeier−
Haack cyclization and intramolecular azomethine ylide cyclo-
addition strategy applied to synthesis of the core of
aspidospermatan alkaloids. This key step proved to be
particularly efficient in generating molecular complexity in very
short order from a linear precursor prepared in only eight steps.
We determined that a methyl enol ether as the nucleophile for
the Vilsmeier−Haack cyclization, an unsaturated ester as the
dipolarophile, and a stabilized azomethine ylide for the final
cycloaddition composed the proper functional group arrange-
ment to ensure perfect chemoselectivity in the one-pot process.
Future work will be aimed at finalizing the total synthesis of a
series of aspidospermatan alkaloids via functional group
manipulations on cycloadduct 51.4,5
■ EXPERIMENTAL SECTION
General Information. All reactions requiring anhydrous conditions
were conducted in flame-dried glassware under a dry nitrogen or argon
atmosphere. Compounds lacking experimental details were prepared
according to the literature as cited and are in agreement with published
spectra. THF was distilled from Na and benzophenone at atmospheric
pressure. DCM, toluene, diisopropylethylamine, triethylamine, and
pyrrolidine were distilled from CaH2 at atmospheric pressure. Triflic
anhydride (Tf2O), TFAA, and chlorobenzene were distilled over a small
amount of P2O5 at atmospheric pressure prior to use. Methanol was
distilled over 4 Å molecular sieves at atmospheric pressure. Zinc powder
was activated with twowashes of 3 NHCl, two washes of EtOH, and two
washes Et2O and then dried under reduced pressure prior to use. 2,6-Di-
tert-butyl-4-methylpyridine (DTBMP) was synthesized following the
reported procedure in literature.24 All other required fine chemicals were
used directly without purification. Thin layer chromatography (TLC)
was conducted with precoated 60 Å 250 μm silica gel plates with F-254
indicator and visualized using a combination of UV and anisaldehyde,
ceric ammonium molybdate, iodine on silica, or potassium permanga-
nate staining. Flash column chromatography was performed using silica
gel (230−400 mesh). IR spectra were recorded with an FTIR
instrument by applying substrates as thin films. 1H and proton-
decoupled 13C NMR spectra were recorded on 300 MHz and/or 400
MHz spectrometers. All chemical shifts are referenced to residual
nondeutarated solvent. 1H NMR coupling constants are reported in
hertz and refer to apparent multiplicities and not true coupling
constants. Data for proton spectra are reported as follows: chemical shift
(multiplicity [singlet (s), doublet (d), triplet (t), quartet (q), quintet
(quint), and multiplet (m)], integration, coupling constants [Hz]).
Carbon spectra were recorded with complete proton decoupling, and
the chemical shifts are reported in ppm. Mass spectra were recorded
with an ESI-Q-TOF instrument.
Usual Reaction Workup and Purification. After addition of the
indicated aqueous solution, layers were separated. The aqueous phase
was extracted with the indicated solvent, and the combined organic
phases were washed with the indicated aqueous solution (if needed),
dried over anhydrous MgSO4, filtered, and concentrated under reduced
pressure using a rotary evaporator. The crude material was purified by
flash chromatography using silica gel with the indicated eluent.
(E)-N-(5-Oxo-3-(3-(trimethylsilyl)prop-1-en-1-yl)hept-6-en-1-
yl)-N-((trimethylsilyl)methyl)formamide (6). Dess-Martin period-
inane (172 mg, 0.41 mmol) was added to a solution of 16 (120 mg, 0.34
mmol) in DCM (7.0 mL). The reaction mixture was stirred for 4 h, then
saturated aqueous NaHCO3 and saturated Na2S2O3 were added, and the
mixture was stirred 30 min. The usual workup (DCM) and purification
(30% EtOAc in hexanes) afforded a mixture of rotamers 6 (108 mg,
91%) as a colorless oil. 1H NMR (300 MHz, CDCl3) δ (ppm) 7.98 (s)
and 7.97 (s) (1H, rotamers), 6.36 (d, J = 10.3 Hz) and 6.30 (d, J = 10.3
Scheme 9. Successful Vilsmeier−Haack/Stabilized
Azomethine Ylide Cycloaddition Sequence.23
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Hz) (1H, rotamers), 6.18 (dd, 1H, J = 17.6, 1.0 Hz), 5.81 (dd, J = 10.3,
1.0 Hz) and 5.80 (dd, J = 10.3, 1.0 Hz) (1H, rotamers), 5.44 (td, 1H, J =
15.0, 7.0 Hz), 5.04 (dd, J = 15.0, 8.0 Hz) and 4.99 (dd, J = 15.0, 8.0 Hz)
(1H, rotamers), 3.19 (t, 2H, J = 7.0 Hz), 2.94 and 2.68 (ABq, JAB = 15.0
Hz) and 2.71 (s) (2H, rotamers), 2.63−2.51 (m, 3H), 1.77−1.61 (m,
1H), 1.42−1.40 (3H, m), 0.10 (s) and 0.08 (s) (9H, rotamers), −0.03
(s) and−0.04 (s) (9H, rotamers). 13CNMR (75MHz, CDCl3) δ (ppm)
199.7, 199.2, 162.3, 161.7, 136.9, 136.8, 130.3, 129.9, 129.2, 128.4, 128.3,
128.2, 47.7, 46.1, 45.8, 43.4, 38.6, 37.0, 36.4, 33.9, 33.3, 32.1, 22.9, 22.8,
−1.2, −1.6, −1.8, −1.9. IR (neat) ν (cm−1) 2954, 2892, 1668, 1402,
1247, 850. HRMS (ESI) Calcd for C18H35NO2Si2Na [MNa
+] 376.2099,
found 376.2108.
4-((tert-Butyldimethylsilyl)oxy)-2-(2-nitroethyl)butanal (10).
Following the reported procedure,7 a solution of pyrrolidine (1.8 μL,
21 μmol), 96 (428mg, 2.11mmol), and 2-nitrobenzoic acid (35mg, 0.21
mmol) in toluene (1 mL) was cooled to 0 °C and then nitroethylene
(2.4 M in toluene, 441 μL, 1.05 mmol) was added. The reaction was
stirred for 2 days at 3 °C. Saturated aqueous NH4Cl was added. The
usual workup (EtOAc) and purification (5% EtOAc in hexanes)
afforded 10 (202 mg, 69%) as a pale yellow oil. 1H NMR (300 MHz,
CDCl3) δ (ppm) 9.66 (s, 1H), 4.56−4.38 (m, 2H), 3.70 (t, 2H, J = 5.7
Hz), 2.59−2.52 (m, 1H), 2.43−2.31 (m, 1H), 2.15−2.08 (m, 1H),
2.01−1.90 (m, 1H), 1.89−1.79 (m, 1H) 0.86 (s, 9H), 0.03 (s, 6H). 13C
NMR (75 MHz, CDCl3) δ (ppm) 202.6 (d), 73.5 (t), 60.0 (t), 46.2 (d),
32.0 (t), 26.0 (q), 25.6 (t), 18.3 (s), −5.4 (q). IR (neat) ν (cm−1) 2929,
2857, 1723, 1551, 1252, 834. HRMS (ESI) Calcd for C12H25NO4SiNa
[MNa+] 298.1445, found 298.1449.
6-((tert-Butyldimethylsilyl)oxy)-4-(2-nitroethyl)hex-1-en-3-ol
(11).Vinylmagnesium bromide (1.0M in THF, 6.8 mL, 6.80mmol) was
added dropwise to a solution of 10 (1.30 g, 4.72 mmol) in THF (50mL)
at −78 °C. The mixture was stirred for 20 min at −78 °C and then 20
min at rt. Saturated aqueous NH4Cl was added. The usual workup
(Et2O) and purification (10 to 15% EtOAc in hexanes) afforded an
inseparable mixture of diastereomers 11 (912mg, 64%) as a colorless oil.
1H NMR (300 MHz, CDCl3) δ (ppm) 5.83 (ddd, 1H, J = 17.0, 10.5, 5.6
Hz), 5.27 (ddt, 1H, J = 17.0, 5.6, 1.5 Hz), 5.21 (dq, 1H, J = 10.5, 1.5 Hz),
4.50−4.41 (m, 2H), 4.12 (dt, 1H, J = 10.5, 4.7 Hz), 3.75−3.62 (m, 2H),
3.03 (br. s, 1H), 2.26−2.10 (m, 1H), 2.04−1.91 (m, 1H), 1.83−1.67 (m)
and 1.64−1.47 (m) (3H), 0.88 (s, 9H), 0.05 (s, 6H). 13C NMR (75
MHz, CDCl3) δ (ppm) 138.9 (d), 138.9 (d), 116.3 (t), 116.1 (t), 74.5
(t), 74.4 (t), 74.4 (t), 74.3 (t), 61.2 (t), 60.6 (t), 39.0 (d), 38.7 (d), 33.4
(t), 32.3 (t), 28.3 (t), 27.7 (t), 26.0 (q), 26.0 (q), 18.4 (s), 18.3 (s),−5.4
(q), −5.4 (q). IR (neat) ν (cm−1) 2953, 2929, 2857, 1725, 1550, 1384,
1254, 1092, 834. HRMS (ESI) Calcd for C14H29NO4SiNa [MNa
+]
326.1758, found 326.1761.
6-((tert-Butyldimethylsilyl)oxy)-4-(2-nitroethyl)hex-1-en-3-yl
2,2,2-trifluoroacetate (12). TFAA (1.00 mL, 7.07 mmol) was added
to a solution of 11 (1.43 g, 4.71 mmol), pyridine (0.57 mL, 7.07 mmol),
and DMAP (115 mg, 0.94 mmol) in DCM (50 mL) at 0 °C. The
reaction mixture was stirred for 20 min at 0 °C. After 1 h at rt, water was
added. The usual workup (DCM) and purification (5% EtOAc in
hexanes) afforded 12 (1.57 g, 84%) as a yellow oil. 1H NMR (300 MHz,
CDCl3) δ (ppm) 5.81 (ddd, 1H, J = 17.0, 10.7, 6.0 Hz), 5.56−5.49 (m,
1H), 5,41 (t, 1H, J = 6.0 Hz), 5.38−5.32 (m, 1H), 4.51−4.44 (m, 2H),
3,71−3.66 (m, 2H), 2.22−2.12 (m, 1H), 2.09−1.99 (m, 2H), 1.73−1.61
(m, 1H), 1.59−1.47 (m, 1H), 0.88 (s, 9H), 0.05 (s, 6H). 19F NMR (282
MHz, CDCl3) δ (ppm) −75.13, −75.19. 13C NMR (75 MHz, CDCl3) δ
(ppm) 156.6 (qd, JC−F = 42.2 Hz, s), 132.0 (d), 131.0 (d), 120.8 (t),
120.2 (t), 114.7 (q, JC−F = 284.0 Hz), 80.8 (d), 80.6 (d), 73.6 (t), 60.6
(t), 60.2 (t), 36.6 (d), 36.2 (d), 32.8 (t), 32.6 (t), 27.8 (t), 27.2 (t), 26.0
(q), 18.3 (q), −5.4 (q). IR (neat) ν (cm−1) 2954, 2930, 2858, 1784,
1555, 1220, 1153, 834. HRMS (ESI) Calcd for C16H28F3NO5SiNa
[MNa+] 422.1581, found 422.1583.
(E)-tert-Butyldimethyl((3-(2-nitroethyl)-6-(trimethylsilyl)hex-
4-en-1-yl)oxy)silane (13). Following the reported procedure,8 a
solution of 12 (3.02 g, 7.56 mmol) in THF (10 mL) was added to a
solution of hexamethyldisilane (3.10 mL, 15.1 mmol) and bis-
(dibenzylideneacetone)palladium (131 mg, 0.23 mmol) in THF (40
mL) at rt. The solution was stirred for 15 h at rt, and then saturated
aqueous NaHCO3 was added. The usual workup (Et2O) and
purification (3% EtOAc in hexanes) gave 13 (2.58 g, 95%) as a
colorless oil. 1H NMR (300 MHz, CDCl3) δ (ppm) 5.43 (dt, 1H, J =
15.5, 8.0 Hz), 4.91 (dd, 1H, J = 15.5, 9.0 Hz), 4.36 (dd, 2H, J = 7.5, 6.8
Hz), 3.67−3.51 (m, 2H), 2.21−2.09 (m, 2H), 1.86−1.73 (m, 1H),
1.67−1.55 (m, 1H), 1.54−1.47 (m, 1H), 1.44 (dd, 2H, J = 8.1, 1.1 Hz),
0.88 (s, 9H), 0.03 (s, 6H), 0.00 (s, 9H). 13C NMR (75 MHz, CDCl3) δ
(ppm) 130.0 (d), 129.6 (d), 74.3 (t), 60.9 (t), 38.7 (t), 37.4 (d), 33.1 (t),
26.1 (q), 23.0 (t), 18.4 (s), 1.8 (q), −5.2 (q). IR (neat) ν (cm−1) 2953,
2928, 2857, 1552, 1248, 1100. HRMS (ESI) Calcd for C17H37NO3Si2Na
[MNa+] 382.2204, found 382.2209.
(E)-3-(2-Nitroethyl)-6-(trimethylsilyl)hex-4-enal (14). Cam-
phorsulfonic acid (2.00 g, 8.60 mmol) was added to a solution of 13
(2.58 g, 7.17 mmol) in MeOH (70 mL). The reaction mixture was
stirred for 30 min, and then water was added. The usual workup
(EtOAc) and purification (20% EtOAc in hexanes) afforded the
corresponding alcohol (1.65 g, 94%) as a colorless oil. 1H NMR (300
MHz, CDCl3) δ (ppm) 5.49 (dt, 1H, J = 15.0, 8.0 Hz), 4.93 (dd, 1H, J =
15.0, 9.0), 4.37 (dd, 2H, J = 7.5, 6.5 Hz), 3.73−3.59 (m, 2H), 2.25−2.13
(m, 2H), 1.87−1.74 (m, 1H), 1.72−1.62 (m, 1H), 1.58−1.51 (m, 1H),
1.45 (d, 2H, J = 8.0, 1.0 Hz), 1.27 (br. s, 1H), 0.01 (s, 9H). 13CNMR (75
MHz, CDCl3) δ (ppm) 130.3, 129.8, 74.1, 60.9, 38.5, 37.8, 33.1, 23.1,
−1.8. IR (neat) ν (cm−1) 2952, 2901, 1549, 1379, 1246, 846. HRMS
(ESI) Calcd for C11H23NO3SiNa [MNa
+] 268.1339, found 268.1342.
Following the procedure used to prepare 6, the alcohol ((1.65 g, 6.72
mmol) in DCM (130 mL) was treated with Dess-Martin periodinane
(3.42 g, 8.07 mmol) for 2 h. The usual workup (DCM) and purification
(10% EtOAc in hexanes) afforded 14 (1.54 g, 94%) as a colorless oil. 1H
NMR (300MHz, CDCl3) δ (ppm) 9.69 (t, 1H, J = 2.0 Hz), 5.55 (dt, 1H,
J = 15.5, 8.0 Hz), 4.99 (dd, 1H, J = 15.5, 9.0 Hz), 4.39 (dd, 2H, J = 7.5, 6.5
Hz), 2.72−2.58 (m, 1H), 2.46 (dd, 2H, J = 6.9, 2.0 Hz), 2.26−2.15 (m,
1H), 1.92−1.80 (m, 1H), 1.44 (dd, 2H, J = 8.0, 1.0 Hz), 0.01 (s, 9H). 13C
NMR (75 MHz, CDCl3) δ (ppm) 201.1, 131.2, 128.0, 73.6, 49.3, 35.4,
32.3, 23.1,−1.8. IR (neat) ν (cm−1) 2953, 2896, 1723, 1549, 1379, 1246,
848. HRMS (ESI) Calcd for C12H27NO4SiNa [M + MeOH + Na
+]
298.1445, found 298.1457.
(E)-5-(2-Nitroethyl)-8-(trimethylsilyl)octa-1,6-dien-3-ol (15).
Following the procedure used to prepare 11, 14 (1.54 g, 6.33 mmol)
in THF (65 mL) was treated with vinylmagnesium bromide (1.0 M in
THF, 9.50 mL, 9.49 mmol) for 40 min at −78 °C and then for 1 h at rt.
The usual workup (Et2O) and purification (12.5 to 20% EtOAc in
hexanes) afforded a separable 1:1 mixture of diastereomers 15 (1.49 g,
87%) as a colorless oil.Diastereomer 1: 1HNMR (300MHz, CDCl3) δ
(ppm) 5.87 (ddd, 1H, J = 17.0, 10.4, 6.0 Hz), 5.53 (dt, 1H, J = 15.0, 8.0
Hz), 5.21 (dt, 1H, J = 17.0, 1.5 Hz), 5.09 (dt, 1H, J = 10.4, 1.5 Hz), 4.91
(ddt, 1H, J = 15.0, 9.2, 1.1 Hz), 4.37 (dd, 2H, J = 8.0, 6.6 Hz), 4.19−4.11
(m, 1H), 2.39−2.26 (m, 1H), 2.21−2.09 (m, 1H), 1.87−1.74 (m, 1H),
1.58−1.43 (m, 5H), 0.01 (s, 9H). 13C NMR (75 MHz, CDCl3) δ (ppm)
141.4, 130.6, 129.6, 114.4, 74.1, 70.6, 43.0, 37.3, 33.3, 23.1, −1.8. IR
(neat) ν (cm−1) 3381, 2951, 2919, 1549, 1430, 1375, 1247, 991, 844.
HRMS (ESI) Calcd for C13H25NO3SiNa [MNa
+] 294.1495, found
294.1499. Diastereomer 2: 1H NMR (300 MHz, CDCl3) δ (ppm) 5.81
(ddd, 1H, J = 17.0, 10.3, 6.5 Hz), 5.46 (dt, 1H, J = 15.0, 8.0 Hz), 5.21 (dt,
1H, J = 17.0, 1.0 Hz), 5.13 (dt, 1H, J = 10.3, 1.0 Hz), 4.98 (ddt, 1H, J =
15.0, 9.0, 1.0 Hz), 4.36 (dd, 2H, J = 8.0, 6.4 Hz), 4.20−4.13 (m, 1H),
2.26−2.07 (m, 2H), 1.85−1.75 (m, 1H), 1.68−1.50 (m, 3H), 1.46 (dd,
2H, J = 8.0, 1.0 Hz), 0.01 (s, 9H). 13C NMR (75 MHz, CDCl3) δ (ppm)
140.6, 130.2, 130.1, 115.7, 73.9, 71.7, 42.9, 37.8, 32.9, 23.1, −1.7. IR
(neat) ν (cm−1) 3386, 2955, 2919, 1545, 1426, 1375, 1247, 991, 844.
HRMS (ESI) Calcd for C13H25NO3SiNa [MNa
+] 294.1496, found
294.1487.
(E)-N-(5-Hydroxy-3-(3-(trimethylsilyl)prop-1-en-1-yl)hept-6-
en-1-yl)-N-((trimethylsilyl)methyl)formamide (16). Following the
reported procedure for reduction of the nitro group,10 acetic acid (1.00
mL, 18.4 mmol) and activated zinc powder (1.20 g, 18.4 mmol) were
added to a solution of 15 (500 mg, 1.84 mmol) in EtOAc (10 mL). After
1 h at rt, the mixture was filtered through a Celite pad and the latter was
washed with EtOAc. The filtrate was concentrated under reduced
pressure, and the crude was diluted with hexanes and then concentrated
(three cycles) in order to remove the remaining acetic acid. K2CO3 (2.55
g, 18.4 mmol) and (iodomethyl)trimethylsilane (0.36 mL, 2.39 mmol)
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were added to the crude amine in THF (10 mL). The reaction mixture
was refluxed for 20 h and then was allowed to cool before being filtering.
N-Formylbenzotriazole (300 mg, 1.84 mmol) was added to the filtrate,
and the reaction mixture was stirred for 15 h at rt. The mixture was
concentrated. The usual purification (12.5 to 20% EtOAc in DCM)
afforded a mixture of rotamers 16 (411 mg, 63%) as a colorless oil. 1H
NMR (300 MHz, CDCl3) δ (ppm) 7.97 (s) and 7.96 (s) (1H,
rotamers), 5.79 (ddd, 1H, J = 17.0, 10.3, 6.7 Hz), 5.39 (dt, 1H, J = 15.5,
8.0 Hz), 5.18 (dt, 1H, J = 17.0, 1.5 Hz), 5.10 (dt, 1H, J = 10.3, 1.5 Hz),
5.07 (ddt, J = 15.5, 9.0, 1.0 Hz) and 4.99 (ddt, J = 15.5, 9.0, 1.0 Hz) (1H,
rotamers), 4.17−4.10 (m, 1H), 3.33−3.22 (m) and 3.17 (t, J = 7.3 Hz)
(2H, rotamers), 2.90 and 2.66 (ABq, JAB = 15.0 Hz) and 2.67 (s) (2H,
rotamers), 2.07−1.95 (m, 1H), 1.79 (br. s, 1H), 1.70−1.31 (m, 6H),
0.09 (s) and 0.07 (s) (9H, rotamers), −0.02 (s, 9H). 13C NMR (75
MHz, CDCl3) δ (ppm) 162.3 (d), 161.8 (d), 141.0 (d), 140.8 (d), 132.1
(d), 131.5 (d), 128.9 (d), 128.2 (d), 115.5 (t), 115.2 (t), 71.9 (d), 71.8
(d), 47.7 (t), 43.6 (t), 43.22 (t), 43.17 (t), 38.8, 38.3, 37.6 (d), 34.1 (t),
34.0 (t), 32.6 (t), 23.0 (t), 22.9 (t), −1.2 (q), −1.7 (q), −1.9 (q). IR
(neat) ν (cm−1) 3376, 2952, 1655, 1389, 1246, 840. HRMS (ESI) Calcd
for C18H37NO2Si2Na [MNa
+] 378.2255, found 378.2265.
(E)-N-(5-(Benzyloxy)-3-(3-(trimethylsilyl)prop-1-en-1-yl)-
hept-6-en-1-yl)-N-((trimethylsilyl)methyl)formamide (19). NaH
(60% dispersion in mineral oil, 92.4 mg, 2.31 mmol) was added to a
solution of 16 (411 mg, 1.16 mmol) in THF (10 mL) at 0 °C. n-Bu4NI
(427 mg, 1.16 mmol) and benzyl bromide (1.37 mL, 11.6 mmol, freshly
distilled) were successively added, and the mixture was stirred for 20 h at
rt. Saturated aqueous NaHCO3 was added. The usual workup (Et2O)
and purification (20% EtOAc in hexanes) afforded a mixture of rotamers
19 (435 mg, 84%) as a colorless oil. 1H NMR (300 MHz, CDCl3) δ
(ppm) 7.89 (s, 1H), 7.32−7.21 (m, 5H), 5.62 (ddd, 1H, J = 17.5, 10.0,
8.0 Hz), 5.30 (dt, 1H, J = 15.5, 8.0 Hz), 5.22 (dd, 1H, J = 10.0, 1.5 Hz),
5.15 (dd, 1H, J = 17.0, 1.5 Hz), 4.95 (d, J = 9.0Hz) and 4.87 (dd, J = 15.0,
9.0 Hz) (1H), 4.38 and 4.37 (ABq, 2H, JAB = 12.0 Hz), 3.77−3.69 (m,
1H), 3.23−3.14 (m) and 3.08 (t, J = 7.0 Hz) (2H), 2.82 and 2.58 (ABq,
JAB = 15.0 Hz) and 2.62 (s) (2H), 2.03−1.90 (m, 1H), 1.69−1.26 (m,
6H),−0.03 (s) and−0.02 (s) (9H),−0.07 (s, 9H). 13C NMR (75MHz,
CDCl3) δ (ppm) 162.2, 161.8, 138.9, 138.8, 138.7, 138.7, 131.8, 131.4,
128.7, 128.5, 128.4, 127.9, 127.9, 127.8, 127.7, 127.6, 127.5, 127.1, 118.0,
117.9, 79.1, 78.8, 70.1, 65.4, 65.4, 47.7, 43.6, 41.5, 41.4, 38.6, 37.5, 36.7,
34.1, 33.9, 32.5, 22.9, 22.8, −1.2, −1.7, −1.8. IR (neat) ν (cm−1) 2954,
2927, 2896, 2862, 1666, 1246. HRMS (ESI) Calcd for C25H43NO2Si2Na
[MNa+] 468.2725, found 468.2737.
4-(2-(Benzyloxy)but-3-en-1-yl)-1-((trimethylsilyl)methyl)-5-
vinyl-2,3,4,5-tetrahydropyridin-1-ium trifluoromethane-
sulfonate (20) and 4-(2-(Benzyloxy)but-3-en-1-yl)-5-ethyl-
idene-1-((trimethylsilyl)methyl)-2,3,4,5-tetrahydropyridin-1-
ium Trifluoromethanesulfonate (21).Tf2O (32 μL, 0.19 mmol) was
added to a solution of 19 (76.0 mg, 0.17 mmol) and DTBMP (38.5 mg,
0.19 mmol) in DCM (3.5 mL) at −78 °C. After 15 min at −78 °C and
then 45 min at rt, 1H NMR analysis of an aliquot showed the formation
of the iminium ion 20: 1H NMR (300 MHz, CD2Cl2) characteristic
signals δ (ppm) 8.19 (s), 7.36−7.30 (m, 5H), 5.81−5.64 (m, 2H), 5.52−
5.45 (m, 1H), 5.32−5.26 (m, 3H), 4.68 (s), and 4.60 and 4.28 (ABq, JAB
= 12.0 Hz) (2H), 3.88−3.75 (m 2H), 3.65−3.46 (m) and 3.31−3.26
(m) (3H), 0.22 (s, 9H). The reaction mixture was concentrated. The
usual purification (0 to 10% MeOH in EtOAc) afforded 21 (65.0 mg,
76%) as a pale yellow oil. 1H NMR (300 MHz, CDCl3) characteristic
signals δ (ppm) 8.61 (s, 1H), 7.36−7.26 (m, 5H), 7.09 (q, 1H, J = 7.0
Hz), 5.76 (ddd, 1H, J = 17.0, 10.5, 8.0 Hz), 5.34−5.28 (m, 2H), 4.70 (s),
and 4.65 and 4.30 (ABq, JAB = 12.0 Hz) (1H), 3.85−3.79 (m,1H), 3.66
(s, 2H), 3.48 (s, 1H), 2.08−2.06 (d, 2H, J = 7.0 Hz), 0.18 (s, 9H).
8-(2-(Benzyloxy)but-3-en-1-yl)-9-ethylidene-2-phenylocta-
hydro-1H-pyrrolo[3,4-a]indolizine-1,3(2H)-dione (23).A solution
of 21 (65.5 mg, 0.13 mmol) and N-phenylmaleimide (112 mg, 0.65
mmol) in DCE (3.0 mL) was heated to reflux, and then TBAT (70 mg,
0.13 mmol) was added. The mixture was refluxed for 14 h, allowed to
cool to rt, and then was concentrated under reduced pressure. The usual
purification (60% EtOAc in hexanes) afforded a mixture of
diastereomers 23 (14.0 mg, 24%) as a pale yellow oil. 1H NMR (300
MHz, CDCl3) δ (ppm) 7.51−7.28 (m, 10H), 5.87−5.72 (m) and 5.66
(q, J = 7.0 Hz) (2H), 5.31−5.24 (m, 2H), 4.67 and 4.37 (ABq, J = 12.0
Hz), and 4.62 and 4.35 (ABq, J = 12.0 Hz) (2H), 3.86−3.34 (m, 5H),
3.20−2.57 (m, 5H), 1.87−1.66 (m, 6H). 13C NMR (75 MHz, CDCl3) δ
(ppm) 177.5, 177.3, 176.4, 176.3, 139.0, 138.97, 138.8, 137.1, 136.7,
132.0, 131.9, 129.2, 129.19, 128.7, 128.6, 128.4, 127.9, 127.8, 127.6,
127.5, 126.6, 126.59, 126.5, 123.8, 119.2, 117.8, 117.5, 78.3, 78.2, 77.4,
70.2, 70.1, 70.0, 65.8, 57.4, 54.9, 50.1, 47.0, 46.6, 45.2, 45.1, 43.5, 39.9,
38.0, 29.9, 29.8, 29.2, 27.8, 26.9, 13.3, 13.0. IR (neat) ν (cm−1) 2919,
2853, 1707, 1497, 1375, 1176, 729, 691. HRMS (ESI) Calcd for
C29H33N2O3 [MH
+] 457.2486, found 457.2486.
Following the above procedure, TBAT (71 mg, 0.13 mmol) was
added to a solution of 21 (65.5 mg, 0.13 mmol) andN-phenylmaleimide
(104 mg, 0.60 mmol) in DCM (3.0 mL) at 0 °C. After 20 h at 0 °C, the
mixture was concentrated under reduced pressure. The usual
purification (60% EtOAc in hexanes) afforded one diastereomer 23
(8.80 mg, 16%) as a pale yellow oil. 1H NMR (300 MHz, CDCl3) δ
(ppm) 7.38−7.20 (m, 10H), 5.74−5.58 (m, 2H), 5.25−5.19 (m, 2H),
4.60 and 4.29 (ABq, 2H, J = 12.0 Hz), 3.81−3.74 (m, 1H), 3.48−3.42
(m, 2H), 3.32−3.26 (m, 2H), 3.10−2.99 (m, 2H), 2.37 (dd, 1H, J =
9.5,7.0 Hz), 2.21 (dt, 1H, J = 10.0 and 4.5 Hz), 1.84−1.75 (m, 2H), 1.72
(dd, 3H, J = 7.0, 2.0 Hz), 1.63−1.56 (m, 2H). 13C NMR (75 MHz,
CDCl3) δ (ppm) 178.7 (s), 175.1 (s), 139.2 (d), 139.0, 135.1, 134.2,
132.1, 129.0 (d), 128.4 (d), 128.2 (d), 127.4 (d), 127.2 (d), 126.7 (d),
122.5 (d), 116.7 (t), 77.8 (d), 69.7 (t), 68.2 (d), 56.6 (t), 47.7 (d), 45.9
(t), 44.2 (d), 41.6 (t), 28.4 (d), 23.7 (t), 12.8 (q). IR (neat) ν (cm−1)
2933, 2859, 1711, 1498, 1383, 1194, 735, 693. HRMS (ESI) Calcd for
C29H32N2O3Na [MNa
+] 479.2305, found 479.2310.
(E)-N-(3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-6-(trimethyl-
silyl)hex-4-en-1-yl)-N-((trimethylsilyl)methyl)formamide (24).
Following the procedure used to prepare 16, 13 (2.0 g, 6.95 mmol)
was treated with acetic acid (3.1 mL, 55.6 mmol) and activated zinc
powder (4.55 g, 69.5 mmol) in EtOAc (35 mL) and then with K2CO3
(9.60 g, 69.5 mmol) and (iodomethyl)trimethylsilane (1.4 mL, 9.04
mmol) in THF (35 mL), followed by the addition of N-formyl-
benzotriazole (1.13 g, 6.95 mmol) directly to the reaction mixture. The
usual purification (10% EtOAc in hexanes) afforded a mixture of
rotamers 24 (2.10 g, 68%) as a pale yellow oil. 1H NMR (300 MHz,
CDCl3) (ppm) 7.98 (s) and 7.96 (s) (1H, rotamers), 5.38 (dt, 1H, J =
15.1, 7.8 Hz), 4.91 (dd, 1H, J = 15.1, 9.1 Hz), 3.65−3.49 (m, 2H), 3.17
(t, 2H, J = 7.4 Hz), 2.79 (ABq, 2H, JAB = 15.0 Hz), 2.12−1.98 (m, 1H),
1.69−1.50 (m, 2H), 1.48−1.30 (m, 4H), 0.88 (s, 9H), 0.08 (s, 9H), 0.02
(s, 6H), −0.01 (s, 9H). 13C NMR (75 MHz, CDCl3) δ (ppm) 162.2,
161.80, 131.8, 131.4, 128.4, 127.7, 61.3, 61.1, 47.9, 43.7, 39.0, 38.9, 38.7,
37., 37.2, 34.1, 34.1, 32.7, 26.1, 22.9, 22.8, 18.4, −1.2, −1.5, −1.8, −5.1.
IR (neat) ν (cm−1) 2952, 2928, 2857, 1680, 1467, 1432, 1389, 1247,
1098, 836. HRMS (ESI) Calcd for C22H49NO2Si3Na [MNa
+] 466.2963,
found 466.2952.
(E)-N-(3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-6-(trimethyl-
silyl)hex-4-en-1-yl)-N-(cyanomethyl)formamide (25). Following
the procedure used to prepare 16, 13 (800 mg, 2.22 mmol) was treated
with acetic acid (1.00 mL, 17.8 mmol) and activated zinc powder (1.45
g, 22.2 mmol) in EtOAc (10 mL) and then with K2CO3 (769 mg, 5.56
mmol) and bromoacetonitrile (162 μL, 2.33 mmol) in THF (22 mL) at
rt for 4 h followed by the addition of N-formylbenzotriazole (360 mg,
2.45 mmol) directly to the reaction mixture. The latter was quenched
with a solution of 1 N NaOH. The usual workup (DCM) and
purification (25% EtOAc in hexanes) afforded a mixture of rotamers 25
(682 mg, 77%) as a colorless oil. 1H NMR (300 MHz, CDCl3) δ (ppm)
8.08 (s) and 8.04 (s) (1H, rotamers), 5.40 (dt, 1H, J = 15.0, 7.8 Hz), 4.93
(dd, 1H, J = 15.0, 9.0 Hz), 4.34 and 4.18 (ABq, 2H, JAB = 17.5 Hz), 3.67−
3.51 (m, 2H), 3.45−3.34 (m, 2H), 2.16−2.04 (m, 1H), 1.79−1.68 (m,
1H), 1.63−1.39 (m, 5H), 0.88 (s, 9H), 0.06 (s, 6H), 0.03 (s, 9H). 13C
NMR (75MHz, CDCl3) δ (ppm) 162.5 (d), 130.8 (d), 129.2 (d), 114.8
(s), 60.9 (t), 46.0 (t), 38.8 (t), 37.1 (d), 33.6 (t), 30.0 (t), 26.1 (q), 23.0
(t), 18.4 (s), −1.7 (q), −5.1 (q). IR (neat) ν (cm−1) 2953, 2929, 2857,
1680, 1471, 1426, 1247, 1098, 835, 774. HRMS (positive ESI) Calcd for
C20H40N2O2Si2Na [MNa
+] 419.2520, found 419.2524.
(E)-N-(3-(2-Hydroxyethyl)-6-(trimethylsilyl)hex-4-en-1-yl)-N-
((trimethylsilyl)methyl)formamide (26). Following the procedure
used to prepare 14, 24 (2.10 g, 4.73 mmol) was treated with camphor
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sulfonic acid (1.32 g, 5.68 mmol) in MeOH (50 mL). The usual workup
(EtOAc) and purification (40% EtOAc in hexanes) afforded a mixture of
rotamers 26 (1.33 g, 85%) as a colorless oil. 1H NMR (300 MHz,
CDCl3) δ (ppm) 7.96 (s) and 7.94 (s) (1H, rotamers), 5.42 (dt, 1H, J =
15.5, 8.0 Hz), 4.99 (dd, J = 15.5, 9.0 Hz) and 4.92 (dd, J = 15.5, 9.0 Hz)
(1H, rotamers), 3,68−3.54 (2H, m), 3.36−3.21 (m) and 3.17 (t, J = 7.5
Hz) (2H, rotamers), 2.90 and 2.66 (ABq, JAB = 15.0 Hz) and 2.69 (s)
(2H, rotamers), 2.11−1.99 (m, 1H), 1.15 (br. s, 1H), 1.69−1.54 (m,
2H), 1.51−1.31 (m, 4H), 0.08 (s) and 0.06 (s) (9H, rotamers),−0.02 (s,
9H). 13C NMR (75 MHz, CDCl3) δ (ppm) 162.4, 161.8, 131.8, 131.2,
128.9, 127.9, 61.0, 60.9, 47.8, 43.5, 38.7, 38.7, 38.4, 37.9, 37.5, 34.1, 34.1,
32.6, 22.9, 22.8, −1.3, −1.7, −1.9. IR (neat) ν (cm−1) 3409, 2929, 2894,
2867, 1653, 1432, 1391, 1246, 843. HRMS (ESI) Calcd for
C16H35NO2Si2Na [MNa
+] 352.2098, found 352.2090.
(E)-N-(Cyanomethyl)-N-(3-(2-hydroxyethyl)-6-(trimethyl-
silyl)hex-4-en-1-yl)formamide (27). Following the procedure used
to prepare 14, 25 (50mg, 0.13mmol) was treated with camphor sulfonic
acid (32.2 mg, 0.14 mmol) in MeOH (1 mL). The usual workup
(EtOAc) and purification (80% EtOAc in hexanes) afforded a mixture of
rotamers 27 (29.9 mg, 84%) as a colorless oil. 1H NMR (300 MHz,
CDCl3) δ (ppm) 8.08 (s) and 8.03 (s) (1H, rotamers), 5.47 (dt, 1H, J =
15.5, 8.0 Hz), 4.95 (dd, 1H, J = 15.5, 9.0 Hz), 4.30 and 4.22 (ABq, JAB =
17.5 Hz) and 4.16 (s) (2H), 3.72−3.57 (m, 2H), 3.40 (dd, 2H, J = 8.0,
6.5 Hz), 2.20−2.08 (m, 1H), 1.83−1.71 (m, 1H), 1.68−1.56 (m, 2H),
1.55−1.41 (m, 4H), 0.00 (s, 9H). 13C NMR (75 MHz, CDCl3) δ (ppm)
162.5 (d), 130.6 (d), 129.7 (d), 114.9 (s), 60.7 (t), 47.0 (t), 38.6 (t), 37.3
(d), 33.6 (t), 30.2 (t), 23.0 (t),−1.7 (q). IR (neat) ν (cm−1) 3425, 2948,
2885, 1667, 1430, 1397, 1177, 1055, 913. HRMS (positive ESI) Calcd
for C14H26N2O2SiNa [MNa
+] 305.1655, found 305.1658.
(E)-N-(3-(2-Oxoethyl)-6-(trimethylsilyl)hex-4-en-1-yl)-N-
((trimethylsilyl)methyl)formamide (28). Following the procedure
used to prepare 14, 26 (919 mg, 2.79 mmol) in DCM (50 mL) was
treated with Dess-Martin periodinane (1.42 g, 3.35 mmol) for 12 h. The
usual workup (DCM) and purification (30% EtOAC in hexanes)
afforded a mixture of rotamers 28 (913 mg, 94%) as a colorless oil. 1H
NMR (300MHz, CDCl3) δ (ppm) 9.67 (t, 1H, J = 2.0 Hz), 8.00 (s) and
7.96 (s) (1H, rotamers), 5.49 (dt, J = 16.0, 8.5 Hz) and 5.48 (dt, J = 16.0,
8.5 Hz) (1H, rotamers), 5.06 (dd, 1H, J = 15.0, 8.5 Hz) and 5.00 (dd, J =
15.0, 8.5 Hz) (1H, rotamers), 3.28 (t, J = 7.5 Hz) and 3.20 (t, J = 7.5 Hz)
(2H, rotamers), 2.94 and 2.64 (ABq, JAB = 15.0 Hz) and 2.70 (s) (2H,
rotamers), 2.59−2.54 (m, 1H), 2.43−2.36 (m, 2H), 1.80−1.51 (m, 2H),
1.49−1.37 (m, 2H), 0.09 (s) and 0.07 (s) (9H, rotamers),−0.03 (s, 9H).
13C NMR (75 MHz, CDCl3) δ (ppm) 202.3, 201.6, 162.3, 161.7, 129.9,
129.4, 129.0, 49.7, 49.4, 47.4, 43.3, 38.7, 35.8, 35.2, 34.0, 33.4, 32.2, 23.0,
22.9,−1.2,−1.6,−1.8,−1.9. IR (neat) ν (cm−1) 2952, 2892, 1723, 1663,
1435, 1391, 1246, 1152, 841. HRMS (ESI) Calcd for C16H33NO2Si2Na
[MNa+] 350.1942, found 350.1938.
(E)-N-(Cyanomethyl)-N-(3-(2-oxoethyl)-6-(trimethylsilyl)hex-
4-en-1-yl)formamide (29). Following the procedure used to prepare
14, 27 (63.0 mg, 0.22 mmol) in DCM (5 mL) was treated with Dess-
Martin periodinane (114 mg, 0.27 mmol) for 1 h. The usual workup
(DCM) and purification (50% EtOAc in hexanes) afforded a mixture of
rotamers 29 (59.4 mg, 95%) as a colorless oil. 1HNMR (8:2) (300MHz,
CDCl3) δ (ppm) 9.70 (t, 1H, J = 1.4 Hz), 8.10 (s) and 8.03 (s) (1H,
rotamers), 5.52 (dt, 1H, J = 15.0, 8.0 Hz), 5.01 (dd, 1H, J = 15.0, 8.0 Hz),
4.42 and 4.21 (ABq, 2H, JAB = 17.5 Hz), 3.41 (dd, 2H, J = 8.0, 6.0 Hz),
2.60−2.51 (m, 1H), 2.49−2.46 (m, 2H), 1.87−1.75 (m, 1H), 1.54−1.47
(m, 1H), 1.45 (dd, 2H, J = 8.0, 1.0 Hz), −0.01 (s, 9H). 13C NMR (75
MHz, CDCl3) δ (ppm) 162.4 (d), 161.9 (d), 130.5 (d), 129.8 (d), 129.2
(d), 128.9 (d), 128.2 (d), 114.8 (s), 49.8 (t), 49.4 (t), 45.6 (t), 41.6 (t),
36.1 (t), 35.3 (d), 34.7 (d), 32.7 (t), 32.0 (t), 30.0 (t), 29.8 (t), 28.4 (t),
23.1 (t),−1.6 (q),−1.8 (q). IR (neat) ν (cm−1) 2955, 2923, 1719, 1673,
1421, 1394, 1243, 1178, 1151, 963, 840. HRMS (positive ESI) Calcd for
C14H24N2O2SiNa [MNa
+] 303.1499, found 303.1503.
Methyl (E)-3-Hydroxy-2-methylene-8-(trimethylsilyl)-5-(2-
(N-((trimethylsilyl)methyl)formamido)ethyl)oct-6-enoate (30).
Following the reported procedure,14 methyl acrylate (0.2 mL, 2.29
mmol, freshly distilled) and DABCO (257 mg, 2.29 mmol) were
successively added to a solution of 28 (75.0 mg, 0.23 mmol) in 1,4-
dioxane/water (1:1) (2mL). After 72 h at rt, water was added. The usual
workup (tert-Butyl methyl ether) and purification (30% EtOAc in
hexanes) afforded 30 as an inseparable mixture of rotamers and
diastereomers (68.4 mg, 72%) as a colorless oil. 1H NMR (400 MHz,
CDCl3) δ (ppm) 7.98−7.95 (m, 1H), 6.23−6.21 (m, 1H), 5.83−5.77
(m, 1H), 5.51 (dt, J = 15.5, 8.0 Hz) and 5.51 (dt, J = 15.5, 8.0 Hz) and
5.42 (dt, J = 15.5, 8.0 Hz) and 5.42 (dt, J = 15.5, 8.0 Hz) (1H), 5.09−
4.98 (m) and 4.93 (dd, J = 15.0, 9.0 Hz) (1H), 4.46−4.39 (m, 1H),
3.78−3.75 (m, 3H), 3.21−3.11 (m, 2H), 2.90 and 2.68 (ABq, JAB = 15.0
Hz) and 2.88 and 2.68 (ABq, JAB = 15.0 Hz) and 2.71 (s) (2H), (2.48−
2.45) (m) and 2.32−3.34 (m) (1H), 1.76−1.68 (m, 1H), 1.61−1.51 (m,
2H), 1.49−1.34 (m, 3H), 0.09−0.07 (m, 9H), 0.01−0.01 (m, 9H). 13C
NMR (75 MHz, CDCl3) δ (ppm) 167.1, 167.0, 162.6, 162.3, 161.8,
143.6, 143.2, 141.9, 141.8, 132.0, 131.6, 131.3, 130.6, 129.7, 129.0, 128.6,
128.3, 125.7, 125.6, 124.8, 124.6, 70.5, 70.4, 68.9, 52.1, 52.0, 51.9, 47.9,
47.6, 43.6, 43.3, 42.4, 42.4, 41.9, 38.7, 38.6, 38.6, 37.9, 37.4, 37.4, 34.5,
34.1, 34.0, 33.4, 33.0, 32.1, 31.1, 23.0, 23.0, 22.9, −1.2, −1.7, −1.8, −1.9.
IR (neat) ν (cm−1) 3392, 2950, 1718, 1650, 1436, 1248, 1152, 842.
HRMS (ESI) Calcd for C20H39NO4Si2Na [MNa
+] 436.2309, found
436.2307.
Methyl (E)-5-(2-(N-(Cyanomethyl)formamido)ethyl)-3-hy-
droxy-2-methylene-8-(trimethylsilyl)oct-6-enoate (31). Follow-
ing the reported procedure,14 29 (1.58 g, 5.63 mmol) in 1,4-dioxane/
water (1:1) (6 mL) was treated with methyl acrylate (5.1 mL, 56.3
mmol) and DABCO (6.3 g, 56.3 mmol) for 78 h. The usual workup
(tert-butyl methyl ether) and purification (20% Et2O in DCM) afforded
as an inseparable mixture of rotamers and diastereomers 31 (1.99 g,
91%) as a yellow oil. 1HNMR (300MHz, CDCl3) δ (ppm) 8.10 (s), and
8.08 (s), and 8.05 (s) (1H), 6.24 (s), and 6.22 (s) (1H), 5.81 (s, 1H),
5.55 (dt, J = 15.5, 8.0 Hz), and 5.46 (dt, J = 15.5, 8.0 Hz) (1H), 5.08−
5.02 (m), and 4.96 (dd, J = 15.5, 9.0 Hz) (1H), 4.48−4.41 (m, 1H), 4.33
and 4.20 (ABq, JAB = 17.5 Hz) and 4.27 (s) (2H), 3.78 (s) and 3.77 (s)
(3H), 3.44−3.38 (2H), 2.39−2.31 (m, 1H), 1.72−1.45 (m, 7H), 0.02
(s) and 0.01 (s) (9H). 13C NMR (75 MHz, CDCl3) δ (ppm) 166.9 (s),
162.3 (d), 143.0 (s), 130.9 (d), 130.3 (d), 129.9 (d), 129.4 (d), 125.5
(t), 124.7 (t), 114.7 (s), 69.9 (d), 68.8 (d), 52.0 (q), 51.9 (q), 45.9 (t),
45.8 (t), 42.2 (t), 37.3 (d), 37.2 (d), 34.0 (t), 32.5 (t), 30.0 (t), 23.0 (t),
22.9 (t), −1.8 (q). IR (neat) ν (cm−1) 3471, 2952, 1716, 1671, 1434,
1246, 1152, 849 HRMS (positive ESI) Calcd for C18H30N2O4SiNa
[MNa+] 389.1867, found 389.1871.
Methyl (E)-3-(Benzyloxy)-2-methylene-8-(trimethylsilyl)-5-
(2-(N-((trimethylsilyl)methyl)formamido)ethyl)oct-6-enoate
(32). Following the procedure used to prepare 19, 30 (312 mg, 0.75
mmol) in THF (8mL) at 0 °Cwas treated with NaH (60% dispersion in
mineral oil, 60.0 mg, 1.51 mmol) and then with n-Bu4NI (279 mg, 0.75
mmol) and benzyl bromide (0.90 mL, 7.54 mmol) for 16 h. The usual
workup (Et2O) and purification (15% EtOAc in hexanes) afforded a
mixture of rotamers and diastereomers 32 (240 mg, 63%) as a colorless
oil. 1H NMR (400 MHz, CDCl3) δ (ppm) 7.99−7.95 (m, 1H), 7.41−
7.32 (m, 5H), 6.38−6.35 (m, 1H), 5.96−5.94 (m, 1H), 5.45−5.21 (m,
1H), 5.08−4.86 (m, 1H), 4.51 and 4.25 (ABq, J = 11.5 Hz), and 4.47 and
4.23 (ABq, J = 11.5 Hz) (2H), 4.38−4.28 (m, 1H), 3.77−3.77 (m, 3H),
3.29−3.19 (m), and 3.18−3.11 (m), and 3.10−3.00 (m) (2H), 2.88 (d, J
= 15.0 Hz), and 2.85 (d, J = 15.0 Hz), and 2. 68 (s), and 2.65 (d, J = 26.0
Hz), and 2.61 (d, J = 26 Hz), 1.69−1.29 (m, 6H), 0.08 (s), and 0.06 (s),
and 0.05 (s) (9H), 0.00 (s) and −0.08 (s) (9H). 13C NMR (75 MHz,
CDCl3) δ (ppm) 166.8 (s), 162.2 (d), 161.7 (d), 141.7 (s), 141.5 (s),
141.0 (s), 138.5 (s), 138.2 (s), 138.2 (s), 131.6 (d), 131.4 (d), 131.1 (d),
129.3 (d), 128.7 (d), 128.6 (d), 128.5 (d), 128.4 (d), 128.2 (d), 128.1
(d), 128.0 (d), 127.9 (d), 127.8 (d), 127.7 (d), 125.7 (t), 125.1 (t), 75.7
(d), 75.5 (d), 75.4 (d), 71.4 (t), 71.1 (t), 52.0 (q), 51.8 (q), 48.0 (t), 47.7
(t), 43.7 (t), 43.6 (t), 43.2 (t), 43.0 (t), 42.3 (t), 38.7 (t), 38.6 (t), 38.3
(d), 37.7 (d), 37.0 (d), 34.6 (t), 34.1 (t), 34.1 (t), 33.0 (t), 32.6 (t), 23.0
(t), 22.9 (t),−1.2 (q),−1.5 (q),−1.6 (q),−1.7 (q),−1.9 (q). IR (neat)
ν (cm−1) 2950, 2888, 1718, 1667, 1519, 1496, 1248, 1192, 1150, 1077,
843. HRMS (positive ESI) Calcd for C27H45NO4Si2Na [MNa
+]
526.2779, found 526.2775.
Methyl (E)-5-(2-(N-(Cyanomethyl)formamido)ethyl)-2-meth-
ylene-3-((triethylsilyl)oxy)-8-(trimethylsilyl)oct-6-enoate (33).
Triethysilyl trifluoromethanesulfonate (65 μL, 0.29 mmol) was added
dropwise to a solution of 31 (88.0 mg, 0.24 mmol) and triethylamine
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(50 μL, 0.36 mmol) in DCM (2.5 mL) at 0 °C. The mixture was stirred
at rt for 1 h 30. Then, water was added. The usual workup (DCM) and
purification (30% EtOAc in hexanes) afforded a mixture of rotamers and
diastereomers 33 (107 mg, 93%) as a colorless oil. 1H NMR (300 MHz,
CDCl3) δ (ppm) 8.03 (s) and 8.02 (s) (1H), 6.22 (s, 1H), 5.91 (s) and
5.87 (s) (1H), 5.47 (dt, J = 15.5, 8.0 Hz) and 5.35 (dt, J = 15.5, 8.0 Hz)
(1H), 5.01 (dd, J = 15.5, 9.0 Hz) and 5.07−4.95 (m) (1H),4.62−5.46
(m, 1H), 4.36 and 4.15 (ABq, JAB = 17.5 Hz), and 4.33 and 4.20 (ABq,
JAB = 17.5 Hz) (2H), 3.74 (s, 3H), 3.42−3.31 (m, 2H), 2.23−2.05 (m,
1H), 1.90−1.37 (m, 6H), 0.96−0.89 (m, 9H), 0.61−0.52 (m, 6H), 0.02
(s) and 0.01 (s) (9H). 13C NMR (76 MHz, CDCl3) δ (ppm) 166.7 (s),
166.6 (s), 162.4 (d), 162.3 (d), 144.9 (s), 143.7 (s), 131.3 (d), 131.1 (d),
129.2 (d), 128.3 (d), 124.9 (t), 124.7 (t), 124.6 (t), 114.8 (s), 69.0 (d),
68.6 (d), 51.8 (q), 51.9 (q), 45.8 (t), 45.7 (t), 45.2 (t), 43.9 (t), 37.5 (d),
36.8 (d), 36.5 (d), 36.1 (t), 34.4 (t), 33.2 (t), 33.0 (t), 30.1 (t), 30.0 (t),
23.2 (t), 22.9 (t), 7.0 (q), 6.9 (q), 5.1 (d), 4.9 (d),−1.7 (q),−1.8 (q). IR
(neat) ν (cm−1) 2953, 2913, 2877, 1718, 1681, 1436, 1247, 1152, 1088,
849. HRMS (positive ESI) Calcd for C24H44N2O4Si2Na [MNa
+]
503.2732, found 503.2741.
4-(2-(Benzyloxy)-3-(methoxycarbonyl)but-3-en-1-yl)-1-
((trimethylsilyl)methyl)-5-vinyl-2,3,4,5-tetrahydropyridin-1-
ium Trifluoromethanesulfonate (34) and 4-(2-(Benzyloxy)-3-
(methoxycarbonyl)but-3-en-1-yl)-5-ethylidene-1-((trimethyl-
silyl)methyl)-2,3,4,5-tetrahydropyridin-1-ium trifluoro-
methanesulfonate (35). Tf2O (32 μL, 190 μmol) was added to a
solution of 33 (47.6 mg, 94 μmol) and DTBMP (21.3 mg, 100 μmol) in
DCM (1.0 mL) at −78 °C. After 20 min, the mixture was allowed to
warm up at rt for 30 min. 1H NMR analysis of an aliquot showed the
formation of the iminium ion 34: 1H NMR (300 MHz, CD2Cl2)
characteristic signals δ (ppm) 8.23 (s) and 8.22 (s) (1H), 7.39−7.30 (m,
5H), 6.39 (s) and 6.38 (s) (1H), 6.00 (s) and 5.96 (s) (1H), 5.74−5.60
(m, 1H), 5.47−5.36 (m, 2H), 4.58 and 4.21 (ABq, J = 11.5 Hz), and 4.50
and 4.27 (ABq, J = 11.5 Hz) (2H), 4.42 (d, J = 3.0 Hz), and 4.40 (d, J =
3.0 Hz), and 5.34 (s) and 4.32 (s) (1H), 3.76 (s) and 3.75 (s) (3H),
1.88−1.78 (m, 2H), 0.21 (s) and 0.20 (s) (9H). The reaction mixture
was concentrated. The usual purification (0 to 10% MeOH in EtOAc)
afforded 35 as brown yellow oil. 1H NMR (300 MHz, CDCl3)
characteristic signals δ (ppm) 8.38 (s, 1H), 7.37−7.26 (m, 5H), 7.07−
6.97 (m, 1H), 6.42 (s, 1H), 6.05 (s) and 6.00 (s) (1H), 4.64 and 4.26
(ABq, J = 11.5 Hz), and 4.54 and 4.24 (ABq, J = 11.5 Hz) (2H), 4.35−
4.30 (m, 1H), 3.67−3.41 (m, 4H), 0.17 (s, 9H).
1-(Cyanomethyl)-5-ethylidene-4-(3-(methoxycarbonyl)-2-
((triethylsilyl)oxy)but-3-en-1-yl)-2,3,4,5-tetrahydropyridin-1-
ium Trifluoromethanesulfonate (39).Tf2O (3.7 μL, 21.7 μmol) was
added to 33 (9.5 mg, 19.8 μmol) and DTBMP (4.5 mg, 21.7 μmol) in
CD2Cl2 (0.6 mL) at 0 °C in anNMR tube. The
1HNMR spectrum of 39
was recorded after 15 min at rt. 1H NMR (300 MHz, CD2Cl2)
characteristic signals δ (ppm) 8.84 (s), and 8.82 (s), and 8.76−8.52 (m)
(1H), 7.35 (q, J = 7.5 Hz), and 7.28−7.18 (m) (1H), 6.32 (s), and 6.27−
6.20 (m) (1H), 6.02 (s), and 6.00−5.86 (m) (1H), 5.15 (s, 1H), 4.80−
4.68 (m, 1H), 3.91−3.86 (m, 1H), 3.76 (s), and 3.75 (s), and 3.74−7.72
(m) (3H), 2.23 (d, J = 7.0 Hz), and 2.17 (d, J = 7.0 Hz) (1H), 0.99−0.90
(m, 9H), 0.67−0.58 (m, 6H).
Methyl 2-Cyano-4-((triethylsilyl)oxy)-7-vinyloctahydro-1,6-
ethanoindole-3a-carboxylate (41). Tf2O (20 μL, 0.14 mmol) was
added to a solution of 33 (49.8 mg, 0.10 mmol) and DTBMP (23.4 mg,
0.14 mmol) in DCM (1.0 mL) at 0 °C. After 15 min, i-Pr2NEt (108 μL,
0.62 mmol) was added at 0 °C. The mixture was then stirred for 3 h at rt.
Saturated aqueous NaHCO3 was added. The usual workup (DCM) and
purification (70% EtOAc in hexanes) afforded 41 in traces. 1H NMR
(300 MHz, CDCl3) characteristic signals δ (ppm) 5.77−5.65 (m, 1H),
5.33−5.23 (m, 2H), 4.68 (t, 1H, J = 6.0 Hz), 3.87 (d, 1H, J = 4.0 Hz),
2.91−2.85 (m, 1H), 2.50 (td, 1H, J = 12.0, 2.5 Hz), 2.29−2.20 (m, 1H),
2.03−1.98 (m, 1H), 1.90−1.83 (m, 1H), 1.37−1.25 (m, 4H), 0.96−0.91
(m, 9H), 0.62−0.54 (m, 6H). HRMS (positive ESI) Calcd for
C21H34N2O3SiNa [MNa
+] 413.2231, found 413.2223.
Methyl 2-Cyano-4-hydroxy-7-vinyloctahydro-1,6-ethano-
indole-3a-carboxylate. Following the procedure used to prepare
41, i-Pr2NEt was added at 80 °C in DCE to afford the corresponding
alcohol in traces. 1H NMR (300 MHz, CDCl3) characteristic signals δ
(ppm) 5.74−5.65 (m, 1H), 5.33−5.23 (m, 2H), 4.46 (dd, 1H, J = 7.6, 5.9
Hz, 1H), 3.88 (d, 1H, J = 4.5 Hz), 2.95−2.85 (m, 1H), 2.55 (td, 1H, J =
12.0, 3.0 Hz), 2.34 (ddd, 1H, J = 10.5, 9.5, 4.4 Hz), 2.08−2.03 (m, 1H),
1.88 (ddd, 1H, J = 14.0, 5.7, 3.6 Hz). HRMS (positive ESI) Calcd for
C15H20N2O3Na [MNa
+] 299.1366, found 299.1367.
tert-Butyl((5-methoxy-3-(2-nitroethyl)pent-4-en-1-yl)oxy)-
dimethylsilane (42). A solution of n-BuLi (2.5 M in hexane, 30.5 mL,
76.2 mmol) was added dropwise to a solution of methoxy-
methyltriphenylphosphonium chloride (26.1 g, 76.2 mmol) in THF
(250mL) at 0 °C. The solution was stirred for 30min at 0 °C, and then a
solution of 10 (7.00 g, 25.4 mmol) in THF (20 mL) was added. The
solution was stirred for 7 h at rt. A buffer solution of acetic acid pH = 4.7
was added. The two layers were separated. The usual workup (EtOAc)
and purification (1 to 2% EtOAc in hexanes) gave a hardly separable 3:1
mixture of E/Z-isomers 42 (4.19 mg, 55%) as a colorless oil. (Z)-42
(minor): 1HNMR (300MHz, CDCl3) δ (ppm) 5.98 (d, 1H, J = 6.0Hz),
4.39−4.34 (m, 2H), 4.04 (dd, 1H, J = 9.5, 6.0 Hz), 3.63−3.51 (m, 2H),
3.55 (s. 3H), 2.76−2.64 (m, 1H), 2.25−2.13 (m, 1H), 1.86−1.73 (m,
1H), 1.68−1.59 (m, 1H), 1.52−1.41 (m, 1H), 0.88 (s, 9H), 0.03 (s, 6H).
13C NMR (75 MHz, CDCl3) δ (ppm) 148.2 (d), 108.1 (d), 74.3 (t),
61.2 (t), 59.7 (q), 38.9 (t), 33.2 (t), 28.8 (d), 26.1 (q), 18.4 (s),−5.2 (q).
IR (neat) ν (cm−1) 2929, 2856, 1662, 1551, 1254, 1097, 834. HRMS
(positive ESI) Calcd for C14H29NO4SiNa [MNa
+] 326.1758, found
326.1742. (E)-42 (major): 1H NMR (300 MHz, CDCl3) δ (ppm) 6.28
(d, 1H, J = 13.0 Hz), 4.41−4.36 (m, 3H), 3.68−3.55 (m, 2H), 3.52 (s.
3H), 2.24−2.10 (m, 2H), 1.89−1.76 (m, 1H), 1.71−1.60 (m, 1H),
1.50−1.39 (m, 1H), 0.88 (s, 9H), 0.03 (s, 6H). 13C NMR (75 MHz,
CDCl3) δ ppm 149.1 (d), 104.2 (d), 74.2 (t), 60.5 (t), 56.3 (q), 39.1 (t),
33.6 (t), 32.9 (d), 26.1 (q), 18.4 (s), −5.2 (q). IR (neat) ν (cm−1) 2929,
2857, 1651, 1551, 1252, 1102, 834. HRMS (positive ESI) Calcd for
C14H29NO4SiNa [MNa
+] 326.1758, found 326.1731.
(E)-N-(3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-5-methoxy-
pent-4-en-1-yl)-N-(cyanomethyl)formamide (43). Following the
procedure used to prepare 16, 42 (2.69 g, 8.86 mmol) was treated with
acetic acid (7.4 mL, 133 mmol) and activated zinc powder (8.70 g, 133
mmol) in EtOAc (40 mL) and then with K2CO3 (6.13 g, 44.3 mmol)
and bromoacetonitrile (930 μL, 13.3 mmol) in THF (90 mL), followed
by the addition ofN-formylbenzotriazole (1.43 g, 9.75 mmol) directly to
the reaction mixture. The usual workup (DCM) and purification (30%
EtOAc in hexanes) afforded a mixture of rotamers 43 (2.30 g, 76%) as a
colorless oil. 1H NMR (300 MHz, CDCl3) δ (ppm) 8.08 (s) and (8.06)
(s) (1H, rotamers), 6.28 (d, J = 12.5 Hz) and 6.26 (d, J = 12.5 Hz) (1H,
rotamers), 4.42−4.15 (m, 3H), 3.67−3.55 (m, 2H), 3.52 (s. 3H), 3.44−
3.38 (m, 2H), 2.14−2.01 (m, 1H), 1.84−1.72 (m, 1H), 1.68−1.57 (m,
1H), 1.53−1.36 (m, 2H), 0.88 (s, 9H), 0.03 (s, 6H). 13C NMR (75
MHz, CDCl3) δ (ppm) 162.4 (d), 161.8 (d, rotamer), 148.7 (d), 148.4
(d, rotamer), 114.8 (s), 105.2 (d, rotamer), 104.9 (d), 60.6 (t, rotamer),
60.4 (t) 56.3 (q), 56.2 (q, rotamer), 46.0 (t), 42.1 (t, rotamer), 39.2 (t),
39.1 (t, rotamer), 36.1 (t, rotamer), 34.1 (t), 33.0 (d, rotamer), 32.4 (d),
30.1 (t), 26.0 (q), 18.3 (s), −5.2 (q). IR (neat) ν (cm−1) 2929, 2855,
1676, 1651, 1250, 1086, 834. HRMS (positive ESI) Calcd for
C17H32N2O3SiNa [MNa
+] 363.2074, found 363.2077.
(E)-N-(Cyanomethyl)-N-(5-methoxy-3-(2-oxoethyl)pent-4-
en-1-yl)formamide (44). A solution of TBAF (1.0 M in THF, 7.4 mL,
7.4 mmol) was added to a solution of 43 (2.30 mg, 6.75 mmol) in THF
(140 mL). After 6 h, saturated aqueous NaCl was added. The usual
workup (Et2O) afforded crude alcohol that was used directly in the next
step. For characterization purposes, a small portion was purified using
usual conditions (2% MeOH in EtOAc) to afford a mixture of rotamers
of the corresponding alcohol as a pale yellow oil. 1H NMR (300 MHz,
CDCl3) δ (ppm) 8.08 (s) and 8.04 (s) (1H, rotamers), 6.32 (d, J = 12.5
Hz) and 6.30 (d, J = 12.5 Hz) (1H, rotamers), 4.39 (dd, 1H, J = 12.5,
10.0 Hz), 4.25 (ABq, J = 17.0 Hz) and 4.17 (s) (2H, rotamers), 3.71−
3.57 (m, 2H), 3.52 (s. 3H), 3.41 (dd, 2H, J = 8.0, 6.5 Hz), 2.16−2.03 (m,
1H), 1.86−1.60 (m, 3H), 1.54−1.41 (m, 2H). 13C NMR (75 MHz,
CDCl3) δ (ppm) 162.6 (d), 162.0 (d, rotamer), 148.8 (d), 148.5 (d,
rotamer), 115.0 (s), 105.2 (d, rotamer), 104.9 (d), 60.5 (t, rotamer),
60.3 (t) 56.4 (q), 56.3 (q, rotamer), 46.1 (t), 42.1 (t, rotamer), 39.0 (t),
38.8 (t, rotamer), 36.2 (t, rotamer), 34.0 (t), 33.2 (d, rotamer), 33.1 (t,
rotamer), 32.6 (d), 30.2 (t). IR (neat) ν (cm−1) 3435, 2930, 1666, 1651,
1428, 1206, 932. HRMS (positive ESI) Calcd for C11H18N2O3Na
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[MNa+] 249.1210, found 249.1210. Following the procedure used to
prepare 6, crude alcohol DCM (140 mL) was treated with Dess-Martin
periodinane (3.44 g, 8.11 mmol) for 14 h. The usual workup (DCM)
and purification (70% EtOAc in hexanes) afforded a mixture of rotamers
44 (1.44 g, 94% over 2 steps) as a colorless oil. 1H NMR (300 MHz,
CDCl3) δ (ppm) 9.68 (s, 1H), 8.08 (s) and (8.03) (s) (1H, rotamers),
6.36 (d, J = 12.5 Hz) and 6.34 (d, J = 12.5 Hz) (1H, rotamers), 4.49−
4.17 (m, 3H), 3.50 (s, 3H), 3.41 (dd. 2H, J = 8.0, 6.0 Hz), 2.50 (s, 3H),
1.88−1.78 (m, 1H), 1.53−1.41 (m, 1H). 13C NMR (75 MHz, CDCl3) δ
(ppm) 201. Seven (d, rotamer), 202.2 (d), 162.4 (d), 162.0 (d,
rotamer), 149.3 (d), 149.1 (d, rotamer), 114.9 (s), 103.9 (d, rotamer),
103.6 (d), 56.4 (q), 56.3 (q, rotamer), 50.4 (t), 50.0 (t, rotamer), 45.5
(t), 41.4 (t, rotamer), 36.0 (t, rotamer), 33.0 (t), 32.4 (t, rotamer), 30.9
(d, rotamer), 30.3 (d), 30.0 (t). IR (neat) ν (cm−1) 2934, 2834, 1717,
1669, 1652, 1428, 1396, 1209, 932. HRMS (positive ESI) Calcd for
C11H16N2O3Na [MNa
+] 247.1053, found 247.1055.
Methyl (E)-5-(2-(N-(Cyanomethyl)formamido)ethyl)-3-hy-
droxy-7-methoxy-2-methylenehept-6-enoate (45). Following
the reported procedure,14 44 (374 mg, 1.67 mmol) in 1,4-dioxane/
water (1:1) (8 mL) was treated with methyl acrylate (1.5 mL, 16.7
mmol) and DABCO (1.87 g, 16.7 mmol) for 72 h. The usual workup
(tert-Butyl methyl ether) and purification (70% EtOAc in hexanes)
afforded a mixture of rotamers and diastereomers 45 (422 mg, 82%) as a
colorless oil. 1HNMR (300MHz, CDCl3) δ (ppm) 8.09 (s) and 8.08 (s)
and 8.06 (s) and 8.04 (s) (1H), 6.39 (d, J = 12.5Hz) and 6.37 (d, J = 12.5
Hz) and 6.30 (d, J = 12.5 Hz) and 6.28 (d, J = 12.5 Hz) (1H), 6.23 (s)
and 6.22 (s) (1H), 5.83 (s) 5.81 (s) (1H), 4.51−4.39 (m, 2H), 4.36−
4.17 (m, 2H), 3.78 (s) and 3.77 (s) (3H), 3.55 (s) and 3.52 (s) (3H),
3.45−3.40 (m, 2H), 2.48 (d, J = 7.0 Hz) and 2.78 (d, J = 7.0 Hz) and
2.53−2.49 (m) (1H), 2.34−2.22 (m) and 2.15−2.03 (m) (1H), 1.94−
1.42 (m, 4H). 13C NMR (75 MHz, CDCl3) δ (ppm) 167.0 (s), 166.9
(s), 162.6 (d), 162.5 (d), 162.1 (d), 162.0 (d), 149.3 (d), 149.2 (d),
148.9 (d), 148.6 (d), 148.4 (d), 143.3 (s), 143.2 (s), 142.0 (s), 125.5 (t),
124.7 (t), 124.6 (t), 115.0 (s), 114.9 (s), 105.3 (d), 105.2 (d), 104.6 (d),
104.2 (d), 103.5 (d), 69.5 (d), 68.5 (d), 68.3 (d), 56.4 (q), 56.3 (q), 56.3
(q), 56.2 (q), 56.1 (q), 52.0 (q), 52.0 (q), 51.9 (q), 46.0 (t), 45.8 (t),
42.8 (t), 42.8 (t), 42.6 (t), 41.9 (t), 41.8 (t), 36.2 (t), 36.1 (t), 34.4 (t),
33.4 (d), 33.1 (t), 33.0 (d), 32.8 (t), 32.7 (d), 32.7 (d), 32.0 (t), 30.2 (t),
30.1 (t), 30.0 (t). IR (neat) ν (cm−1) 3477, 2950, 1712, 1668, 1653,
1434, 1397, 1207, 1142, 935. HRMS (positive ESI) Calcd for
C15H22N2O5Na [MNa
+] 333.1421, found 333.1424.
Methyl (E)-3-Acetoxy-5-(2-(N-(cyanomethyl)formamido)-
ethyl)-7-methoxy-2-methylenehept-6-enoate (46). Following
the reported procedure,20 a solution of DCC (190 mg, 0.92 mmol)
and DMAP (8.7 mg, 0.07 mmol) in DCM (1 mL) was added to a
solution of 45 (220 mg, 0.71 mmol) and acetic acid (43 μL, 0.74 mmol)
inDCM (3mL). Themixture was stirred for 2 h. Then, water was added.
The usual workup (DCM) and purification (65% EtOAc in hexanes)
afforded a mixture of rotamers and diastereomers 46 (136 mg, 55%) as a
colorless oil. 1HNMR (300MHz, CDCl3) δ (ppm) 8.09 (s) and 8.08 (s)
and 8.06 (s) and 8.05 (s) (1H), 6.29−6.22 (m, 2H), 5.80 (s) and 5.75
(s) (1H), 5.67 (dd, J = 8.5, 4.0 Hz) and 5.59 (dd, J = 8.5, 4.0 Hz) (1H),
4.50−4.15 (m, 3H), 3.78 (s) and 3.77 (s) (3H), 3.55 (s) and 3.52 (s)
(3H), 3.44−3.39 (m, 2H), 2.08 (s) and 2.07 (s) (3H), 2.02−1.62 (m,
4H), 1.51−1.40 (m, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 170.2
(s), 169.8 (s), 165.8 (s), 165.7 (s), 162.4 (d), 161.8 (d), 149.5 (d), 149.1
(d), 148.7 (d), 140.7 (s), 140.5 (s), 139.9 (s), 139.7 (s), 126.0 (t), 125.0
(t), 124.9 (t), 114.9 (s), 114.8 (s), 104.9 (d), 104.0 (d), 103.7 (d), 70.3
(d), 70.2 (d), 70.1 (d), 69.9 (d), 56.5 (q), 56.3 (q), 52.2 (q), 52.1 (q),
46.0 (t), 45.6 (t), 42.3 (t), 41.4 (t), 41.3 (t), 36.3 (t), 34.2 (t), 33.9 (d),
33.8 (d), 33.2 (d), 33.1 (d), 32.8 (t), 30.3 (t), 30.1 (t), 21.2 (q), 21.1 (q).
IR (neat) ν (cm−1) 2935, 1736, 1720, 1675, 1653, 1434, 1370, 1232, 935.
HRMS (positive ESI) Calcd for C17H24N2O6Na [MNa
+] 375.1527,
found 375.1531.
Methyl (E)-4-Acetoxy-2-cyano-7-(methoxymethylene)-
octahydro-1,6-ethanoindole-3a-carboxylate (51). Tf2O (53 μL,
0.31 mmol) was added to a solution of 46 (100 mg, 0.28 mmol) and
DTBMP (64.1 mg, 0.31 mmol) in DCM (3.0 mL) at rt. After 5 min, the
mixture was diluted with chlorobenzene (500 mL) and heated to 125
°C. Then i-Pr2NEt (494 μL, 2.84 mmol) was added. The mixture was
stirred for 20 min. Saturated aqueous NaHCO3 was added. The usual
workup (DCM) and purification (30 to 60% EtOAc in hexanes)
afforded two separable portions of two diastereomers of 51: portion 1
(27.8 mg) as a mixture of a colorless oil and solid and portion 2 (17.1
mg) as a mixture of a yellow oil and solid (47% global yield). Portion 1
(two diastereomers): 1H NMR (300 MHz, CDCl3) δ (ppm) 6.10 (s),
and 6.00 (s), and 5.99 (s) (1H), 5.38 (dd, J = 12.0, 7.0 Hz), and 6.20 (dd,
J = 11.0, 7.0 Hz) (1H), 4.47 (s), and 4.46 (s), and 4.20(s) (1H), 3.97
(ddd, J = 10.0, 7.0, 2.5 Hz), and 3.90 (t, J = 8.5 Hz) (1H), 3.71 (s), and
3.70 (s), and 3.69 (s), and 3.68 (s) (3H), 3.64 (s), and 3.58 (s), and 3.55
(s) (3H), 3.31−3.29 (m, 1H), 3.27−3.09 (m, 1H), 2.62−2.42 (m, 3H),
2.31 (ddd, 1H, J = 14.0, 11.0, 7.0 Hz), 2.03 (s), and 2.00 (s) (3H), 1.98−
1.87 (m, 1H), 1.81−1.75 (m, 1H), 1.36 (ddd, 1H, J = 14.0, 12.0, 3.5 Hz).
13C NMR (75 MHz, CDCl3) δ 174.5 (s), 170.8 (s), 170.3 (s), 170.0 (s),
143.4 (d), 143.2 (d), 141.9 (d), 120.8 (s), 117.6 (s), 110.6 (s), 110.4 (s),
109.8 (s), 71.0, 69.8, 65.5, 62.5, 60.1, 60.0, 59.4 (s), 58.1 (s), 57.4 (s),
54.4, 52.9, 52.0, 51.7, 45.7 (t), 45.4 (t), 42.2 (t), 38.4 (t), 38.0 (t), 36.6
(t), 34.7 (t), 33.0 (t), 32.5 (t), 29.8 (t), 27.6 (d), 27.3 (t), 26.9 (t), 26.2
(t), 25.1 (s), 21.3 (q), 21.20 (q). IR (neat) ν (cm−1) 2950, 2935, 1730,
1694, 1434, 1373, 1235, 1203, 1127. HRMS (positive ESI) Calcd for
C17H22N2O5Na [MNa
+] 357.1421, found 357.1435. Portion 2 (two
diastereomers): 1H NMR (300 MHz, CDCl3) δ (ppm) 6.12 (s), and
6.09 (s), and 6.07 (s) and 6.02 (s), and 5.96 (s) (1H), 5.47 (dd, J = 10.5,
7.0 Hz), and 5.32 (dd, J = 11.5, 7.0 Hz) (1H), 4.04−3.93 (m, 1H), 3.86
(dd, 1H, J = 11.0, 6.0 Hz), 3.74 (s), and 3.72 (s), and 3.69 (s) (3H), 3.63
(s), and 3.61 (s), and 3.58 (s) (3H), 3.31−3.13 (m, 1H), 3.07−2.88 (m,
1H), 2.81−2.69 (m, 1H), 2.64−2.41 (m, 2H), 2.26 (ddd, 1H, J = 14.0,
11.5, 7.0 Hz), 1.99 (s, 3H), 1.78−1.66 (m, 1H), 1.39−1.12 (m, 1H). 13C
NMR (75 MHz, CDCl3) δ 174.6 (s), 171.5 (s), 171.0 (s), 170.3 (s),
170.2 (s), 169.9 (s), 142.3 (d), 141.7 (d), 141.6 (d), 118.0 (s), 117.9 (s),
117.5 (s), 111.5 (s), 111.2 (s), 110.1 (s), 109.5 (s), 74.8 (d), 73.8 (d),
71.5 (d), 71.0 (d), 68.2 (d), 66.6 (d), 61.5 (q), 61.2 (q), 60.5 (q), 60.1
(q), 60.0 (q), 59.9 (q), 58.6 (s), 58.3 (s), 58.1 (s), 55.7, 54.1, 53.0, 52.9,
52.4, 52.2, 46.3 (t), 45.3, 44.7 (t), 42.4 (t), 40.4 (t), 39.5 (t), 36.1 (t),
33.3 (s), 33.1 (t), 31.3 (t), 31.2 (t), 31.1 (t), 30.5, 29.9 (s), 29.8 (s), 26.3
(t), 25.0 (s), 23.1 (q), 23.0 (q), 21.2 (q), 21.2 (q). IR (neat) ν (cm−1)
2948, 2933, 1730, 1693, 1435, 1372, 1236, 1206, 1127. HRMS (positive
ESI) Calcd for C17H22N2O5Na [MNa
+] 357.1421, found 357.1392.
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